Anger, confusion spread over UK’s new COVID travel rules
NAIROBI, Kenya (AP) — Travellers and authorities from India and some African countries are furious — and confused — about Britain's new COVID-19 travel rules, calling them discriminatory.
The British government announced what it billed as a simplification of the rules last week, including allowing fully vaccinated travellers arriving in England from much of the world to skip quarantine and take fewer tests.
But the fine print on who was considered “fully vaccinated” is proving far more complicated.
In order to skip self-isolation, travellers must have received a vaccine under the American, British or European programmes or have received a UK-authorised shot from an approved health body.
Bodies in more than a dozen countries in Asia, the Caribbean and the Middle East made it to the list — but India did not, nor did any in Africa.
Countries like Kenya, which has received hundreds of thousands of doses of the AstraZeneca vaccine from the UK itself, were left wondering why their vaccination programmes don't appear to be good enough in the eyes of the British government.
That's leading to concerns that the rules could exacerbate already worrying vaccine hesitancy in Africa as some people question whether the doses available there don't measure up.
Kenya's government noticed “significant public concern” in the wake of the new rules. South African Medical Association chairwoman Dr Angelique Coetzee said citizens were being “discriminated against” and it's “totally unacceptable.” South African authorities objected not only to the new quarantine rules but also to the fact that the country remains on the UK's so-called red list, from which all travel is severely restricted.
The Hindustan Times, one of India's leading English-language dailies, called the decision “illogical and harmful” in an editorial.
Shashi Tharoor, a leader of India's main opposition Congress party, said he had cancelled his upcoming book tour of Britain in protest.
“Why should Indians be deemed to be lesser breeds than others?” he wrote Tuesday on The Quint news website.
The UK Department for Transport, which issued the rules, didn't immediately respond to a request for comment.
But since the initial furore, Britain has walked back one aspect that caused particular consternation: Doses of AstraZeneca made in India, known as Covishield, were initially not on the list of approved vaccines.
The Indian-made product hasn't been formally authorised by UK regulators, although some doses have been used in Britain — and millions were shipped to low- and middle-income country.
Covishield was added to the UK's list of approved vaccines for travellers on Wednesday, but the group of approved public health bodies remained unchanged — meaning the practical effect of the move is limited.
Outrage over Covishield was particularly pointed in India, where the vast majority of people have been vaccinated with the shot.
Before Covishield was added to Britain's travel list, Indian Foreign Secretary Harsh Vardhan Shringla told reporters this week: “We understand that this has been used in (Britain's) National Health System and therefore non-recognition of Covishield is a discriminatory policy.”
Shringla said the rules, which take effect next month, could force India to “impose reciprocal measures” if the issue isn't resolved.
The government has yet to officially comment on the change, but even after it, outrage continued to pour out from Indians on social media.
“India's digital certification is far more reliable than other countries' manual systems. Is UK trying to make money on PCR tests?” tweeted Kiran Mazumdar-Shaw, founder of Indian pharmaceutical company Biocon.
For African nations, the new UK rules are a setback after a glimmer of hope following India's announcement this week that it will resume exports and donations of surplus coronavirus vaccines in October —after a monthslong freeze because of a surge in domestic infections.
Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at email@example.com or firstname.lastname@example.org.